ascopubs.org

Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study ...

Phase 1 study of anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody MK-0482 + pembrolizumab + gemcitabine + nab-paclitaxel (Gem/Nab-P) in patients (pts) with metastatic pancreatic ductal ...
Block Club Chicago

Disney II English Teacher Wins Golden Apple Award For Personalized Approach To Learning

Heather Debby uses short videos she designed to help students learn at their own pace. She’s “the hardest-working person in ...
ascopubs.org

First-in-human phase 1/2a study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 + endocrine therapy (ET): Updated safety data in patients with HR+ ...

Interim analysis of ABM-1310, a blood-brain barrier-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.
Rotten Tomatoes

Sign up for the Rotten Tomatoes newsletter to get weekly updates on:

Link to What to Watch: In Theaters and On Streaming ...